Primary hypothyroidism
ICD-10 E03.9 · ICD-11 5A00

Severe Primary Hypothyroidism Presenting with Hypothermia and Altered Mental Status

Medical Emergency

This protocol addresses severe primary hypothyroidism presenting with hypothermia, mental status changes — including lethargy, confusion, or stupor — and associated systemic compromise. Rapid, structured management is essential.

Severe primary hypothyroidism can manifest with hypothermia and a spectrum of mental status changes — from lethargy and confusion to psychosis — alongside hypotension, bradycardia, hypoventilation, and diffuse nonpitting edema. At its most extreme, this presentation may represent myxedema coma, a medical emergency most commonly encountered in older patients with primary hypothyroidism and associated with a high mortality rate.

This presentation warrants intensive care unit admission. Management centres on intravenous thyroid hormone replacement, with an alternative combination regimen available for select cases. Concurrent hormonal support targeting a potential co-existing adrenal condition is initiated as part of the early approach, pending exclusion of adrenal insufficiency. The full sequencing, agent selection, and clinical decision points are in the structured protocol.

Thyroid-stimulating hormone (TSH) level should drop by 50% per week on adequate treatment.
References

Clinical features include hypothermia and mental status changes (e.g., lethargy, confusion, psychosis), hypotension, bradycardia, hypoventilation, and diffuse nonpitting edema.

Rarely, severe hypothyroidism can cause myxedema coma, a medical emergency most commonly found in older patients with primary hypothyroidism, with a 25% to 60% mortality rate.

Levothyroxine should be given as a slow intravenous bolus of 200 to 400 mcg initially, followed by 50 to 100 mcg (about 1.6 mcg per kg) orally per day.

For combination treatment, T3 is given at the same time as levothyroxine and dosed at 5 to 20 mcg, then 2.5 to 10 mcg every eight hours until clinical improvement.

Stress-dose glucocorticoids (e.g., 100 mg of hydrocortisone intravenously every eight hours) should be administered until adrenal insufficiency is ruled out.

Possible myxedema coma: intensive care unit admission and endocrinology referral.

The TSH level should drop by 50% per week on adequate treatment.

View source ↗